TipRanks
Advertisement
Advertisement

DE:6FV Stock Latest News

SoftOx taps inhaled antibiotic pioneer Bruce Montgomery to steer SIS clinical strategy
Company AnnouncementsSoftOx taps inhaled antibiotic pioneer Bruce Montgomery to steer SIS clinical strategy
6d ago
6FV
Analyst Group Initiates Equity Research Coverage of SoftOx Solutions
PremiumCompany Announcements
Analyst Group Initiates Equity Research Coverage of SoftOx Solutions
12d ago
6FV
SoftOx Solutions Registers New Share Capital After Private Placement and Debt Conversion
PremiumCompany Announcements
SoftOx Solutions Registers New Share Capital After Private Placement and Debt Conversion
1M ago
6FV
SoftOx starts proof-of-concept patient trial for novel inhaled infection therapy
PremiumCompany Announcements
SoftOx starts proof-of-concept patient trial for novel inhaled infection therapy
2M ago
6FV
SoftOx Chairman Increases Stake as Private Placement Closes
PremiumCompany Announcements
SoftOx Chairman Increases Stake as Private Placement Closes
3M ago
6FV
SoftOx Raises NOK 5.75 Million Through Private Placement and Debt Conversion
PremiumCompany AnnouncementsSoftOx Raises NOK 5.75 Million Through Private Placement and Debt Conversion
3M ago
6FV
SoftOx Advances SIS-03 After Positive Safety Data in Cystic Fibrosis Trial
Premium
Company Announcements
SoftOx Advances SIS-03 After Positive Safety Data in Cystic Fibrosis Trial
3M ago
6FV
SoftOx registers expanded share capital after private placement
Premium
Company Announcements
SoftOx registers expanded share capital after private placement
4M ago
6FV
SoftOx Solutions Calls June 2026 General Meeting for Shareholders
PremiumCompany Announcements
SoftOx Solutions Calls June 2026 General Meeting for Shareholders
4M ago
6FV
SoftOx raises capital through targeted private placement to Long State
PremiumCompany Announcements
SoftOx raises capital through targeted private placement to Long State
4M ago
6FV
SoftOx Advances SIS-03 Trial Into Proof-of-Concept Phase for Chronic Airway Infections
PremiumCompany Announcements
SoftOx Advances SIS-03 Trial Into Proof-of-Concept Phase for Chronic Airway Infections
4M ago
6FV
SoftOx launches second clinical trial for inhaled anti-infective SIS with first participant enrolled
PremiumCompany Announcements
SoftOx launches second clinical trial for inhaled anti-infective SIS with first participant enrolled
4M ago
6FV
SoftOx Solutions Publishes Approved 2025 Annual Report
PremiumCompany AnnouncementsSoftOx Solutions Publishes Approved 2025 Annual Report
4M ago
6FV
SoftOx Registers Share Capital Increase After NOK 7.2m Private Placement
Premium
Company Announcements
SoftOx Registers Share Capital Increase After NOK 7.2m Private Placement
6M ago
6FV
SoftOx Raises Capital via Targeted Private Placement to Long State
Premium
Company Announcements
SoftOx Raises Capital via Targeted Private Placement to Long State
6M ago
6FV
SoftOx Registers New Share Capital After NOK 3.6 Million Private Placement
PremiumCompany Announcements
SoftOx Registers New Share Capital After NOK 3.6 Million Private Placement
6M ago
6FV
SoftOx Raises Capital Through Targeted Private Placement to Long State
PremiumCompany Announcements
SoftOx Raises Capital Through Targeted Private Placement to Long State
7M ago
6FV
SoftOx Starts Key Phase 2a Trial for Inhaled Cystic Fibrosis Therapy
PremiumCompany Announcements
SoftOx Starts Key Phase 2a Trial for Inhaled Cystic Fibrosis Therapy
7M ago
6FV
SoftOx Wins Irish Approval for First-in-Human Trial of Inhaled Antimicrobial Therapy
PremiumCompany Announcements
SoftOx Wins Irish Approval for First-in-Human Trial of Inhaled Antimicrobial Therapy
7M ago
6FV
SoftOx Registers Share Capital Increase After Private Placement
PremiumCompany AnnouncementsSoftOx Registers Share Capital Increase After Private Placement
8M ago
6FV
SoftOx Raises Capital Through Directed Share Issue to Long State Investments
Premium
Company Announcements
SoftOx Raises Capital Through Directed Share Issue to Long State Investments
8M ago
6FV
SoftOx Wins Danish Green Light for Phase 2a Trial of Inhaled Antimicrobial Therapy
Premium
Company Announcements
SoftOx Wins Danish Green Light for Phase 2a Trial of Inhaled Antimicrobial Therapy
9M ago
6FV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >